259
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Microbiological Characterization and Clinical Facets of Elizabethkingia Bloodstream Infections in a Tertiary Care Hospital of Eastern India

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, &
Pages 3257-3267 | Received 03 Mar 2023, Accepted 17 May 2023, Published online: 24 May 2023

References

  • Choi MH, Kim M, Jeong SJ, et al. Risk factors for Elizabethkingia acquisition and clinical characteristics of patients, South Korea. Emerg Infect Dis. 2019;25(1):42–51. doi:10.3201/eid2501.171985
  • Kim KK, Kim MK, Lim JH, Park HY, Lee ST. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. Int J Syst Evol Microbiol. 2005;55(3):1287–1293. doi:10.1099/ijs.0.63541-0
  • Li Y, Kawamura Y, Fujiwara N, et al. Chryseobacterium miricola sp. nov., A novel species isolated from condensation water of space station mir. Syst Appl Microbiol. 2003;26(4):523–528. doi:10.1078/072320203770865828
  • Kämpfer P, Matthews H, Glaeser SP, Martin K, Lodders N, Faye I. Elizabethkingia anophelis sp. nov., isolated from the midgut of the mosquito Anopheles gambiae. Int J Syst Evol Microbiol. 2011;61(11):2670–2675. doi:10.1099/ijs.0.026393-0
  • Nicholson AC, Gulvik CA, Whitney AM, et al. Revisiting the taxonomy of the genus Elizabethkingia using whole-genome sequencing, optical mapping, and MALDI-TOF, along with proposal of three novel Elizabethkingia species: Elizabethkingia bruuniana sp. nov., Elizabethkingia ursingii sp. nov., and Elizabethkingia occulta sp. nov. Antonie van Leeuwenhoek. 2018;111(1):55–72. doi:10.1007/s10482-017-0926-3
  • Cheng YH, Perng CL, Jian MJ, et al. Multicentre study evaluating matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of clinically isolated Elizabethkingia species and analysis of antimicrobial susceptibility. Clin Microbiol Infect. 2019;25(3):340–345. doi:10.1016/j.cmi.2018.04.015
  • Lin JN, Lai CH, Yang CH, Huang YH. Comparison of clinical manifestations, antimicrobial susceptibility patterns, and mutations of fluoroquinolone target genes between elizabethkingia meningoseptica and elizabethkingia anophelis isolated in Taiwan. JCM. 2018;7(12):538. doi:10.3390/jcm7120538
  • Lin JN, Lai CH, Yang CH, Huang YH. Elizabethkingia infections in humans: from genomics to clinics. Microorganisms. 2019;7(9):295. doi:10.3390/microorganisms7090295
  • Chaudhury N, Paul R, Misra RN, Chaudhuri SS, Mirza S, Sen S. Evaluating the trends of bloodstream infections by nonfermenting gram negative bacilli among the patients in a tertiary care hospital of western part of India and its antibiogram. IntJCurrMicrobiolAppSci. 2019;8(01):1149–1162. doi:10.20546/ijcmas.2019.801.121
  • Chiu CT, Lai CH, Huang YH, Yang CH, Lin JN. Comparative analysis of gradient diffusion and disk diffusion with agar dilution for susceptibility testing of Elizabethkingia anophelis. Antibiotics. 2021;10(4):450. doi:10.3390/antibiotics10040450
  • Lai CH, Wong WW, Chin C, et al. Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients. Clin Microbiol Infect. 2006;12(10):986–991. doi:10.1111/j.1469-0691.2006.01511.x
  • Hashimoto T, Komiya K, Fujita N, et al. Risk factors for 30-day mortality among patients with Stenotrophomonas maltophilia bacteraemia. Infect Dis. 2020;52(6):440–442. doi:10.1080/23744235.2020.1734653
  • Asgarani E, Ghashghaei T, Soudi MR, Alimadadi N. Enterobacterial repetitive intergenic consensus (ERIC) PCR based genetic diversity of Xanthomonas spp. and its relation to xanthan production. Iran J Microbiol. 2015;7(1):38–44.
  • Sarwat T, Yousuf M, Khan AS, Kakru DK, Dutta R. Prevalence and antibiogram of non-fermenting Gram-negative bacilli in blood stream infections: study in a tertiary care centre, Western Uttar Pradesh, India. Trop Doct. 2021;51(3):322–325. doi:10.1177/0049475520979298
  • Gautam V, Thapar R, Ray P, Samanta P. Emerging resistance of non-fermenting gram negative bacilli in a tertiary care centre. Indian J Pathol Microbiol. 2011;54(3):666. doi:10.4103/0377-4929.85150
  • Singh S, Sahu C, Singh Patel S, Singh S, Ghoshal U. Clinical profile, susceptibility patterns, speciation and follow up of infections by Elizabethkingia species: study on a rare nosocomial pathogen from an intensive care unit of north India. New Microbes New Infect. 2020;38:100798. doi:10.1016/j.nmni.2020.100798
  • Lau SKP, Chow W-N, Foo C-H. Elizabethkingia anophelis bacteremia is associated with clinically significant infections and high mortality. Sci Rep. 2016;10:26045. doi:10.1038/srep26045
  • Zajmi A, Teo J, Yeo CC. Epidemiology and characteristics of Elizabethkingia spp. infections in Southeast Asia. Microorganisms. 2022;10(5):882. doi:10.3390/microorganisms10050882
  • Ghafur A, Vidyalakshmi PR, Priyadarshini K, Easow JM, Raj R, Raja T. Elizabethkingia meningoseptica bacteremia in immunocompromised hosts: the first case series from India. South Asian J Cancer. 2013;02(04):211–215. doi:10.4103/2278-330X.119912
  • Seong H, Kim JH, Kim JH, et al. Risk factors for mortality in patients with elizabethkingia infection and the clinical impact of the antimicrobial susceptibility patterns of Elizabethkingia species. JCM. 2020;9(5):1431. doi:10.3390/jcm9051431
  • Wan Q, Ye Q, Huang F. The bacteremia caused by non-lactose fermenting gram-negative bacilli in solid organ transplant recipients. Surg Infect. 2015;16(5):479–489. doi:10.1089/sur.2015.005
  • Li Y, Liu T, Shi C, et al. Epidemiological, clinical, and laboratory features of patients infected with Elizabethkingia meningoseptica at a tertiary hospital in Hefei City, China. Front Public Health. 2022;10:964046. PMID: 36225778; PMCID: PMC9549487. doi:10.3389/fpubh.2022.964046
  • Bhatt K, Agolli A, Patel MH, et al. Guerra Del Castillo R, Sanchez-Gonzalez M. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries. 2021;9(1):e126. PMID: 34036149; PMCID: PMC8137279. doi:10.15190/d.2021.5
  • Hu S, Lv Y, Xu H, Zheng B, Xiao Y. Biofilm formation and antibiotic sensitivity in Elizabethkingia anophelis. Front Cell Infect Microbiol. 2022;28(12):953780. doi:10.3389/fcimb.2022.953780
  • Gonzalez LJ, Vila AJ. Carbapenem resistance in Elizabethkingia meningoseptica is mediated by metallo-β-lactamase BlaB. Antimicrob Agents Chemother. 2012;4:1686–1692. doi:10.1128/AAC.05835-11
  • Lin JN, Lai CH, Yang CH, Huang YH, Lin HH. Clinical manifestations, molecular characteristics, antimicrobial susceptibility patterns and contributions of target gene mutation to fluoroquinolone resistance in Elizabethkingia anophelis. J Antimicrob Chemother. 2018;73(9):2497–2502. doi:10.1093/jac/dky197
  • Tang HJ, Lin YT, Chen CC, et al. Molecular characteristics and in vitro effects of antimicrobial combinations on planktonic and biofilm forms of Elizabethkingia anophelis. J Antimicrob Chemother. 2021;76:1205–1214. doi:10.1093/jac/dkab018
  • Ceyhan M, Yıldırım I, Tekelı A, et al. A Chryseobacterium meningosepticum outbreak observed in 3 clusters involving both neonatal and non-neonatal pediatric patients. Am J Infect Control. 2008;36(6):453–457. doi:10.1016/j.ajic.2007.09.008
  • Guimarães A de S, Dorneles EMS, Andrade GI, et al. Molecular characterization of Corynebacterium pseudotuberculosis isolates using ERIC-PCR. Vet Microbiol. 2011;153(3–4):299–306. doi:10.1016/j.vetmic.201